{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:31:11Z","timestamp":1788957071898,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bonr.2026.101902","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:39:32Z","timestamp":1769531972000},"page":"101902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessing cortical bone changes with Romosozumab after one year: Insights from an exploratory HR-pQCT study"],"prefix":"10.1016","volume":"28","author":[{"given":"Mar\u00eda Bel\u00e9n","family":"Zanchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gonzalez-Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Jerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesica","family":"Pingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Erdociain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Rub\u00e9n","family":"Zanchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bonr.2026.101902_bb0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/BOR.0000000000000183","article-title":"Role of cortical bone in bone fragility","volume":"27","author":"Bala","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9","key":"10.1016\/j.bonr.2026.101902_bb0010","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-forming and Antiresorptive effects of Romosozumab in postmenopausal women with osteoporosis: bone Histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"16","key":"10.1016\/j.bonr.2026.101902_bb0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bonr.2026.101902_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf119","volume":"9","author":"Damm","year":"2025","journal-title":"JBMR Plus."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.4457","article-title":"(2022) modeling-based bone formation after 2months of Romosozumab treatment: results from the FRAME clinical trial","volume":"37","author":"Eriksen","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jbmr.2932","article-title":"Effects of romosozumab compared with teriparatide on bone density and mass at the spine and hip in postmenopausal women with low bone mass","volume":"32","author":"Genant","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","article-title":"Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures","volume":"31","author":"Kanis","year":"2020","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bonr.2026.101902_bb0040","first-page":"190","article-title":"Least significant changes and monitoring time intervals for high-resolution pQCT-derived bone outcomes in postmenopausal women","volume":"15","author":"Kawalilak","year":"2015","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"9","key":"10.1016\/j.bonr.2026.101902_bb0045","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/jbmr.3176","article-title":"Greater gains in spine and hip strength for Romosozumab compared with Teriparatide in postmenopausal women with low bone mass","volume":"32","author":"Keaveny","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.bonr.2026.101902_bb0050","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00198-024-07139-9","article-title":"A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis","volume":"35","author":"Kumar","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"11","key":"10.1016\/j.bonr.2026.101902_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf151","article-title":"Effects of romosozumab and teriparatide on hip bone using 3D-SHAPER in postmenopausal women with osteoporosis","volume":"9","author":"Lewiecki","year":"2025","journal-title":"JBMR Plus."},{"issue":"4","key":"10.1016\/j.bonr.2026.101902_bb0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","article-title":"Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis","volume":"79","author":"Makras","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"5","key":"10.1016\/j.bonr.2026.101902_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bonr.2026.101902_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"15","key":"10.1016\/j.bonr.2026.101902_bb0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0085","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jbmr.3240","article-title":"Cortical and trabecular bone microarchitecture as measured with HR-pQCT and the risk of nonvertebral fractures in older adults","volume":"34","author":"Samelson","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.bonr.2026.101902_bb0090","first-page":"S43","article-title":"Reproducibility of HR-pQCT measurements in women with normal BMD and postmenopausal women with osteoporosis","volume":"22","author":"Silveira","year":"2011","journal-title":"Osteoporos. Int."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jbmr\/zjad015","article-title":"Rapid bone microarchitecture decline in older men with high bone turnover-the prospective STRAMBO study","volume":"39","author":"Szulc","year":"2024","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bonr.2026.101902_bb0100","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00198-021-05925-3","article-title":"Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study","volume":"32","author":"Tominaga","year":"2021","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bonr.2026.101902_bb0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00223-023-01087-y","article-title":"Nonresponder considerations for Romosozumab treatment","volume":"113","author":"Tominaga","year":"2023","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00774-024-01570-y","article-title":"Responders and non-responders to romosozumab treatment","volume":"43","author":"Tominaga","year":"2025","journal-title":"J. Bone Miner. Metab."},{"issue":"1","key":"10.1016\/j.bonr.2026.101902_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jbmr.2922","article-title":"Impaired bone microarchitecture improves after one year on gluten-free diet: a prospective longitudinal HRpQCT study in women with celiac disease","volume":"32","author":"Zanchetta","year":"2017","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bonr.2026.101902_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf041","article-title":"How does bone recover in patients with tumor-induced osteomalacia? Long-term follow-up in a national cohort study","volume":"9","author":"Zanchetta","year":"2025","journal-title":"JBMR Plus"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:04:00Z","timestamp":1771056240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":24,"alternative-id":["S2352187226000069"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101902","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing cortical bone changes with Romosozumab after one year: Insights from an exploratory HR-pQCT study","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101902"}}